Physician profile
Brian L Ferris
NPI 1104859081
$169,710.02
in general payments reported to CMS, 2019-2025
21 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $12K · 2021: $22K · 2022: $22K · 2023: $16K · 2024: $6,776 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,250 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,820 · Travel and Lodging: $4,319 · Food and Beverage: $1,798 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,250.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,820.00 |
| Travel and Lodging | $4,318.50 |
| Food and Beverage | $1,798.19 |
| Education | $108.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $111,364.29 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $23,679.44 | 2019-2024 | Embold Fibered, Varithena Administration Pack, Eluvia |
| Biocompatibles, INC. | $23,350.44 | 2019 | |
| Medtronic Vascular, INC. | $6,674.56 | 2019-2020 | |
| Medtronic, INC. | $2,949.68 | 2021-2023 | Endurant Iis |
| Philips North America LLC | $537.55 | 2019-2024 | (6536) Phoenix |
| Cook Medical LLC | $296.20 | 2019-2025 | Zilver Ptx |
| Abbvie INC. | $257.40 | 2024 | |
| Silk Road Medical, INC. | $140.58 | 2022 | |
| Access Vascular INC | $109.33 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $71.65 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $66.41 | 2019-2020 | |
| Inari Medical, INC. | $58.58 | 2021 | |
| Abbott Laboratories | $30.39 | 2019 | |
| Siemens Medical Solutions USA, INC. | $25.88 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $23.22 | 2023 | Puraply |
| Penumbra, INC. | $17.00 | 2021 | |
| Ekos Corporation | $16.00 | 2019 | |
| Davol INC. | $15.69 | 2019 | |
| Cardiva Medical, INC. | $13.73 | 2021 | |
| W. L. Gore & Associates, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ferris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.